<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig0005">
 <label>Fig. 1</label>
 <caption>
  <p>
   <bold>Crystal structure of CCR5.</bold> Crystal structure of CCR5 from RCSB PDB data bank (
   <ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/" id="intr0005" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.rcsb.org/</ext-link>) presented with ChimeraX molecular visualization program. A) 4MBS (CCR5, resolution 2.71 Angstroms) molecule, without contact with any ligand/inhibitor, display of the entire domain is shown in cartoon mode and colored in blue. The surface with transparency in red highlights only transmembrane regions of CCR5. B) 5UIW (CCR5 in complex with high potency HIV entry inhibitor 5P7âˆ’CCL5, resolution 2.20 Angstroms) molecule display of the entire domain is shown in cartoon mode and colored in purple. The surface with transparency (colored in orange) emphasizes subtle changes in the spatial conformation of the molecule when in contact with the inhibitor colored in green. Crystallography: 
   <xref rid="bib1460" ref-type="bibr">Tan et al. (2013)</xref> for 4MBS and 
   <xref rid="bib1690" ref-type="bibr">Zheng et al. (2017)</xref> for 5UIW.
  </p>
 </caption>
 <alt-text id="at0060">Fig. 1</alt-text>
 <graphic xlink:href="gr1_lrg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
